A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
A Case of Acute Promyelocytic Leukemia after Iodine-131 Treatment for Thyroid Cancer
The Korean Journal of Hematology
Radioactive iodine ( 131 I) has been used in the treatment of thyroid cancer to eliminate residual thyroid tissue after thyroidectomy and to treat metastatic disease. Leukemia has rarely been reported as a late complication of 131 I therapy, occurring most frequently after receiving a cumulative activity of 800 mCi of the radioisotope. Although FAB M3 type (acute promyelocytic leukemia, APL) as the secondary acute leukemia had been rarely reported, recently there have been a few cases ofdoi:10.5045/kjh.2006.41.4.302 fatcat:x4d534prdrasteymulw2kj4zu4